Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 7Not yet recruiting 5Completed 5Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 206Neoplasms 191Carcinoma, Non-Small-Cell Lung 91Colorectal Neoplasms 89Prostatic Neoplasms 78Lung Neoplasms 73Multiple Myeloma 49Head and Neck Neoplasms 47Melanoma 46Pancreatic Neoplasms 43Neoplasm Metastasis 42Leukemia, Myeloid, Acute 41Carcinoma, Hepatocellular 40Recurrence 34Brain Neoplasms 34Squamous Cell Carcinoma of Head and Neck 33Ovarian Neoplasms 31Glioblastoma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Glioma 27Uterine Cervical Neoplasms 26Sarcoma 26Lymphoma, Non-Hodgkin 26Lymphoma 26Stomach Neoplasms 25Lymphoma, Follicular 24Carcinoma, Renal Cell 24Esophageal Neoplasms 22Colonic Neoplasms 22Rectal Neoplasms 21

Interventions

Letrozole 2Ritonavir 1Itraconazole 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Advanced Breast Cancer × 90 days × Clear all
NCT06710990 2026-06-04

Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
17 enrolled
Breast

Advanced Breast Cancer

NCT07178743 2026-05-12

Emulation of the PALOMA-2 Trial

Brigham and Women's Hospital

Completed
6,097 enrolled
Breast

Advanced Breast Cancer

NCT07225790 2026-05-12

Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases

Brigham and Women's Hospital

Completed
3,883 enrolled
Breast

Advanced Breast Cancer

NCT07274709 2026-05-12

Emulation of the MONALEESA-2 Trial Using Specialty Oncology Electronic Health Records Databases

Brigham and Women's Hospital

Completed
2,495 enrolled
Breast

Advanced Breast Cancer

NCT03850873 2026-04-09

A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Completed
40 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡